InterCure Ltd. (TLV:INCR)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
272.00
-17.40 (-6.01%)
Feb 5, 2026, 5:34 PM IDT
-53.63%
Market Cap148.73M -46.6%
Revenue (ttm)243.12M -10.8%
Net Income-70.93M
EPS-1.41
Shares Out54.68M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume165,011
Average Volume63,042
Open280.70
Previous Close289.40
Day's Range272.00 - 296.90
52-Week Range272.00 - 644.90
Beta0.32
RSI27.32
Earnings DateMar 30, 2026

About InterCure

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company has a strategic alliance with Cannasoul R&D Ltd. for the research, development, and commercialization of evidence-based cannabis therapeutics. The company was incorporated in 1994 ... [Read more]

Sector Healthcare
Founded 1994
Employees 320
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol INCR
Full Company Profile

Financial Performance

In 2024, InterCure's revenue was 238.85 million, a decrease of -32.82% compared to the previous year's 355.55 million. Losses were -67.80 million, 9.42% more than in 2023.

Financial Statements